Share Twitter LinkedIn Facebook Email Randall A. Oyer, MD, explains the immunotherapy data coming out of the Annual Meeting 2018 and the purpose of the ACCC Immuno-Oncology Institute.
Edetek’s CONFORM Platform: Streamlining Clinical Data Management in Oncology Trials General 3 Mins Read
High-Dose Chemotherapy for Recurrent Germ Cell Tumors: ASCO 2024 Study Results – Hedyeh Ebrahimi, MD – City of Hope ASCO Annual Meeting 2 Mins Read
